Fed. Circ. Rebuffs Attack On Skelaxin Invalidity Ruling

Law360, New York (August 2, 2010, 5:45 PM EDT) -- A federal appeals court on Monday rejected King Pharmaceuticals Inc.'s challenge to a lower court's conclusion that two patents King asserted against Eon Labs Inc. in a lawsuit over the muscle relaxant Skelaxin were invalid.

A three-judge panel of the U.S. Court of Appeals for the Federal Circuit affirmed a trial judge's decision to grant Eon summary judgment.

But though the appeals court reached the same conclusion as the lower court, it took issue with some of the trial judge's analysis.

The opinion said the district...
To view the full article, register now.